All-trans retinoic acid promotes a differential regulation of adhesion molecules on acute myeloid leukaemia blast cells |
| |
Authors: | R Di Noto E M Schiavone F Ferrara † C Manzo C Lo Pardo L Del Vecchio |
| |
Institution: | Divisione di Oncologia Sperimentale C, Immunogia, Istituto Nazionale dei Tumori de Napoli;Servizio di Immunoematologia, Laboratorio di Immunocitologia, Ospedale A. Cardarelli, Napoli;Divisione di Ematologia, Ospedale A. Cardarelli, Napoli, Italy |
| |
Abstract: | Summary. In the present study we investigated the membrance expression of selectin ligands (CD15/Lex, CDw65/VIM2, CD15s/sLex), β2 integrins (CD11a/LFA-1, CD11b/Mac-1) and CD45 phosphatase isoforms (CD45RA, CD45RO on leukaemic cells from 28 patients with acute myeloid malignancies cultured with and without all-trans retinioc acid (ATRA). Within each adhesion system, ATRA was bale to differentially regulate distinct molecules. Furthermore, it was able to exert effects specific for acute promyelocytic leukaemia (APL) blast cells, as well as to induce a series of non-cytotype-restricted phenotypic changes. An impressive feature of ATRA induction was a simultaneous increase in the expression of CD15, CDw65 and CD11b on leukaemic promyelocytes. The sialylated antigen CD15s, however, Showed results independent from the other two carbohydrates (CD15 and CDw65), suggesting a differential enzymatic regulation within the selectin ligands system. In spite of the well-recognized expression of CD11a throughout all stages of normal myeloid differentiation, APL blast cells were found to virtually lack LFA-1 expression. Moreover, ATRA was unable to promote and up-regulation of this antigen in APL, while inducing a frequent down-modulation in non-APL cases constitutively expressing this antigen. In APL cases ATRA generated an asynchronous phenotype (CD15+, CDw65+, CD11b+, CD11a-), undetectable on normally maturing myeloid cells, but consistent with the concept that incomplete differentation, in terms of surface molecule expression, can be sufficient to obtain therapeutic results. |
| |
Keywords: | AML APL all-trans retinoic acid cell adhesion molecules differtiation therapy |
|
|